Addex to Participate at the Benchmark Company Healthcare House Call Conference

Addex’s Dipraglurant Restores Synaptic Plasticity in Models of Dystonia

Addex Convenes Annual General Meeting 2021

Addex Reports Q1 2021 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Q1 2021 Financial Results and Host Conference Call on May 5, 2021

Addex Increases Issued Share Capital to Create Treasury Shares

Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum

Addex to Present at the 20th Annual Needham Virtual Healthcare Conference

Addex Files Registration Statement on Form F-3 with the US Securities and Exchange Commission

Addex Reports Full Year 2020 Financial Results and Provides Corporate Update